Milad Soleimani
- Cancer Research top 0.5%
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 3
-
- Autophagy in Disease and Therapy 2
-
- Cancer-related Molecular Pathways 2
-
- Force Microscopy Techniques and Applications 1
-
- Innovations in Concrete and Construction Materials 1
-
- Virus-based gene therapy research 1
-
- Cancer Mechanisms and Therapy 1
-
- Bone Tissue Engineering Materials 1
- Co-authors
- Arunoday BhanSubhrangsu S. MandalYousef MohammadiVahid Haddadi‐AslNaser AhmadbeigiMohammad Fallahi‐SichaniAmir AtashiEhsan Arefian
- Journals
- Cancer Research (2 papers)Frontiers in Immunology (1 paper)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesIranUnited Arab Emirates
In The Last Decade
Milad Soleimani
13 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Cancer Research 2.0k
- Molecular Biology 1.9k
- Pulmonary and Respiratory Medicine 189
- Endocrinology 25
- Epidemiology 166
Countries citing papers authored by Milad Soleimani
This map shows the geographic impact of Milad Soleimani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milad Soleimani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milad Soleimani more than expected).
Fields of papers citing papers by Milad Soleimani
This network shows the impact of papers produced by Milad Soleimani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milad Soleimani. The network helps show where Milad Soleimani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Milad Soleimani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 13 | |
| 5 | 2022 | 14 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 1 | |
| 8 | 2018 | 9 | |
| 9 | 2018 | 1 | |
| 10 | 2017 | 8 | |
| 11 | Long Noncoding RNA and Cancer: A New Paradigmbreakdown → | 2017 | 2127 |
| 12 | 2015 | 4 | |
| 13 | 2014 | 6 | |
| 14 | 2007 | 62 |
About Milad Soleimani
Milad Soleimani is a scholar working on Periodontics, Cancer Research and Building and Construction, having authored 14 papers that have together received 2.3k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Autophagy in Disease and Therapy (2 papers), Cancer-related Molecular Pathways (2 papers), Force Microscopy Techniques and Applications (1 paper), Innovations in Concrete and Construction Materials (1 paper), Virus-based gene therapy research (1 paper), Cancer Mechanisms and Therapy (1 paper) and Bone Tissue Engineering Materials (1 paper). The work is most often cited by research in Cancer Research (2.0k citations), Molecular Biology (1.9k citations) and Pulmonary and Respiratory Medicine (189 citations). Milad Soleimani has collaborated with scholars based in United States, Iran and United Arab Emirates. Frequent co-authors include Arunoday Bhan, Subhrangsu S. Mandal, Yousef Mohammadi, Vahid Haddadi‐Asl, Naser Ahmadbeigi, Mohammad Fallahi‐Sichani, Amir Atashi, Ehsan Arefian, Jafar Kiani and Mohsen Shahandashti. Their work appears in journals such as Cancer Research, Frontiers in Immunology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.